Sanofi SA (FRA:SNW)
€ 94.22 1.72 (1.86%) Market Cap: 117.88 Bil Enterprise Value: 127.32 Bil PE Ratio: 21.94 PB Ratio: 1.59 GF Score: 89/100

Sanofi SA at Cowen HealthCare Conference Transcript

Mar 02, 2020 / 05:00PM GMT
Release Date Price: €85.57 (+2.44%)
Stephen Michael Scala
Cowen and Company, LLC, Research Division - MD & Senior Research Analyst

Well, good morning, once again. And we'd like to welcome Sanofi to the Cowen Conference. Representing the company is Bill Sibold, who is Executive Vice President of Sanofi Genzyme, one of the most important parts of the company. And Bill, you were going to make a few comments to start.

William J. Sibold
Sanofi - EVP of Sanofi Genzyme

Well, thanks, Steve, and thanks for having me here today. Just to set the frame a little bit, since our Capital Markets Day in December, we've talked about our Play to Win approach and we're making, I'd say, great progress there. The strategy really includes 4 key pillars. Focusing on growth, leading with innovation, accelerating efficiencies, and finally reinventing how we do work, and maybe just a couple of comments on the first to focus on growth. And obviously, a key driver of growth for us is Dupixent. And we've really been looking at Dupixent as we've given the guidance that we think this is going to be a greater than EUR 10

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot